Anis Ahmed Khan

Title: Anis Ahmed Khan: Innovator in Anti-RSV Therapeutics

Introduction

Anis Ahmed Khan is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medicine, particularly in the development of treatments for respiratory syncytial virus (RSV) infections. His innovative work has led to the creation of a patent that addresses critical health challenges.

Latest Patents

Anis Ahmed Khan holds a patent for "Dosage regimens for and compositions including anti-RSV antibodies." This patent describes methods for treating or preventing RSV infection in patients. The methods include dosing regimens for administering a composition that contains a fixed dose of an anti-RSV monoclonal antibody or an antigen-binding fragment thereof. Additionally, the patent outlines pharmaceutical compositions aimed at the treatment or prevention of RSV infection, including a pharmaceutical unit dose that features nirsevimab. He has 1 patent to his name.

Career Highlights

Throughout his career, Anis has worked with prominent companies in the pharmaceutical industry. He has been associated with MedImmune Limited and Sanofi Pasteur Inc., where he contributed to the advancement of medical therapies. His expertise in the field has been instrumental in developing innovative solutions for viral infections.

Collaborations

Anis has collaborated with various professionals in his field, including his coworker Vadryn Pierre. These collaborations have fostered an environment of innovation and have led to significant advancements in therapeutic approaches.

Conclusion

Anis Ahmed Khan is a distinguished inventor whose work in anti-RSV therapeutics has made a meaningful impact on public health. His patent and career achievements reflect his dedication to improving treatment options for viral infections. His contributions continue to inspire future innovations in the medical field.